Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum InMed Pharmaceuticals Inc INM

InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. The Company is engaged in developing a pipeline of prescription-based products, including rare cannabinoids and cannabinoid analogs, targeting the treatment of diseases with high unmet medical needs, as well as developing proprietary manufacturing technologies to produce rare cannabinoids for sale in the health and wellness... see more

NDAQ:INM - Post Discussion

View:
Post by Bullknit101 on May 24, 2021 12:08pm

This Week

Will there a big medical component in the new legislation? https://www.marijuanamoment.net/federal-cannabis-legalization-bill-coming-this-week-newsletter-may-24-2021/
Comment by gainwidpatience on May 25, 2021 10:34am
Imo.. Hedge companies are in total control of this stock with heavy shorting or grabbing at cheap price. Over the last few years, management never spent money on investor awareness unlike Tetra and Willow. Unless the volume comes with more retail participation, it will always remain at the mercy of hedge companies.